Clostridium perfringens infection in dogs (Clostridiosis)
- Synonyms: Clostridia-associated enteritis
- Occurrence: common
- Location of disease: Abdomen/pelvis
When to visit the vet?
Urgent see a veterinarian within 24 hours
If the condition worsens / symptoms persist, consult a veterinarian.
You can find an interesting overview of gastrointestinal problems in dogs, supplemented with information on the intestinal microbiome and the importance of probiotics, here: https://petsvetcheck.de/fachbeitrag/magen-darm-probleme-beim-hund/
The most important facts at a glance
Clostridium perfringens is an anaerobic, gram-positive bacterium found in the environment and the intestinal tract of many animals, including dogs. It can survive in low-oxygen conditions and form spores that are very resilient. In dogs, types A and C are predominantly widespread, with type A being the most common. An infection can be caused by dysbiosis—an imbalance of the intestinal flora / gut microbiota favored by stress, dietary changes, or existing illnesses. Symptoms include Diarrhea, bloody or mucoid stools, Vomiting, Abdominal pain, Fever, weakness, and loss of appetite.
Diagnosis is made through clinical examination and specific tests, such as stool examinations and PCR, to detect the presence of the bacteria. Blood tests can assess the dog’s general health. Treatment includes antibiotics like metronidazole or tylosin, fluid administration to prevent dehydration, and an easily digestible diet. Probiotics can help stabilize the intestinal flora / gut microbiota. The prognosis is generally good if the disease is recognized and treated early. Prevention includes a stable diet, regular veterinary check-ups, and good hygiene practices to minimize the risk of infection.
Causes
Clostridium perfringens is an anaerobic, gram-positive bacterium that is widespread in the environment and also occurs in the intestinal tract of many animals, including dogs. It is known for its ability to survive and multiply in low-oxygen conditions. These bacteria are capable of forming spores that are very resilient in the environment and can survive for a long time even under unfavorable conditions.
There are different types of Clostridium perfringens, which are classified based on their toxins. These toxins are proteins produced by bacteria that can damage the host. The most common types in dogs are Type A and Type C, with Type A being the most frequent. These types differ in how they affect the intestinal tract and which symptoms they cause.
The causes of a Clostridium perfringens infection can be varied. Often, the infection is triggered by dysbiosis, a disruption in the balance of the intestinal flora / gut microbiota, which leads to an excessive multiplication of Clostridium perfringens. stress, a sudden dietary change, or a pre-existing illness can also increase the risk of infection.
Symptoms
Symptoms of a Clostridium perfringens infection in dogs vary depending on the severity and the type of bacteria involved. One of the most common symptoms is Diarrhea, which can occur as acute or chronic. The Diarrhea can be bloody and mixed with mucus, indicating inflammation of the intestinal wall.
In addition to Diarrhea, dogs may also show Vomiting, Abdominal pain, and Flatulence. In severe cases, dehydration and Weight loss can occur, especially if the Diarrhea persists over a longer period.
Another possible symptom is Fever, although it does not occur in all affected dogs. Some dogs also show signs of general discomfort, such as Lethargy and loss of appetite.
Therapy
Treatment for a Clostridium perfringens infection in dogs usually involves a combination of drug therapy and supportive care. Antibiotics such as metronidazole or tylosin can be used to fight the bacterium and relieve symptoms. The choice of antibiotic depends on the sensitivity of the bacterial strain detected in the tests.
In addition to antibiotic therapy, it is important to keep the dog sufficiently hydrated, especially if they have Diarrhea. Intravenous fluids may be necessary to compensate for the loss of fluids and electrolytes and to prevent dehydration. In less severe cases, oral fluid intake may also be sufficient.
Nutritional management also plays an important role in treatment. An easily digestible, low-fiber diet can help relieve symptoms and promote healing of the intestinal tract. In some cases, the veterinarian may also recommend probiotics to support the intestinal flora / gut microbiota and prevent re-infection.
Prognosis and follow-up care
The prognosis for dogs with a Clostridium perfringens infection is generally good, especially if the disease is detected and treated early. Most dogs respond well to treatment and recover completely. Diarrhea and other symptoms usually subside within a few days after starting treatment.
In severe cases or if the infection is not treated in time, complications such as severe dehydration or a secondary bacterial infection can occur, which can worsen the prognosis. However, long-term consequences are rare, and most dogs return to their normal state of health after treatment.
It is important to follow the veterinarian’s instructions carefully and monitor the dog closely during the recovery phase to ensure that it recovers completely.
Prevention
The prevention of a Clostridium perfringens infection in dogs focuses on minimizing risk factors and promoting a healthy intestinal flora / gut microbiota. A balanced and stable diet is crucial to reduce the risk of dysbiosis. Sudden changes in diet should be avoided, and any transition should be gradual.
Regular veterinary checkups can help detect and treat potential health problems early before they lead to an infection. Monitoring the dog’s health and following vaccination and deworming schedules are also important preventive measures.
Hygiene plays an essential role in preventing infections. Contact with potentially contaminated environments or food should be avoided, and the dog’s living space should be kept clean and free of waste. In multi-pet households, animals should be fed separately to prevent the transmission of pathogens.
Outlook on current research
Research is moving away from equating “detection = cause” toward a more precise understanding based on genetics, toxin profiles, and host factors. It is not the mere presence of C. perfringens that is decisive—many dogs carry it—but which genes are active (e.g., cpe for enterotoxin, netF in hemorrhagic cases) and under what conditions they are expressed. Modern whole-genome analyses help distinguish pathogenic strains from harmless commensals, while metagenomics and metabolomics clarify how dysbiosis, lack of fiber, or dietary changes trigger toxin formation. In parallel, spore biology is being studied: spores ensure environmental persistence and relapses; biofilm research examines how bacteria hide in mucus layers and evade therapy.
Diagnostically, the focus is shifting to targeted PCR panels (toxin/Net genes) and quantitative thresholds, combined with clinical data, instead of culture alone or non-specific toxin ELISAs. Therapeutically, antibiotic stewardship is at the forefront: antibiotics where they are needed—and dietary interventions (highly digestible, adjusted fibers), pre-/probiotic consortia, or postbiotics for microbiome management. Initial approaches with bacteriophages against C. perfringens are being tested preclinically; fecal microbiota transplantation (FMT) remains a case-by-case option in studies. Looking ahead, clinical algorithms will combine genetic profiles, microbiome signatures, and symptoms to predict relapse risk and select the most effective therapy—with fewer side effects, a more stable intestinal barrier, and faster recovery.
Frequently Asked Questions (FAQs)
1. What is C. perfringens in dogs?
2. What causes symptoms?
3. Is every lab detection relevant?
4. Which tests are useful?
5. When are antibiotics needed?
6. What role does diet play?
7. Do probiotics help?
8. Risk of relapse?
9. Contagious to humans/animals?
10. What does the future bring?
Literature
- Park, J., Cheon, D., & Oh, Y. I. (2025). Prevalence and toxin gene profiles of Clostridium perfringens in diarrheic dogs and cats in Korea: A retrospective analysis. Journal of Veterinary Science, 26(4), Article e52. https://doi.org/10.4142/jvs.24361
- Wessely, V., Suchodolski, J. S., Cavasin, J. P., Holz, M., Busch-Hahn, K., & Unterer, S. (2025). Prevalence of Clostridium perfringens encoding the netF toxin gene in dogs with acute and chronic gastrointestinal diseases. Pets, 2, Article 9. https://doi.org/10.3390/pets2010009
- Gohari, I. M., Kropinski, A. M., Weese, S. J., Whitehead, A. E., Parreira, V. R., Boerlin, P., Prescott, J. F., & Slavić, D. (2020). NetF-producing Clostridium perfringens and its associated diseases in dogs and foals. Journal of Veterinary Diagnostic Investigation, 32(2), 230–238. https://doi.org/10.1177/1040638720906814
- Leipig-Rudolph, M., Busch, K., Prescott, J. F., Gohari, I. M., Leutenegger, C. M., Hermanns, W., Wolf, G., Hartmann, K., Verspohl, J., & Unterer, S. (2018). Intestinal lesions in dogs with acute hemorrhagic diarrhea syndrome associated with netF-positive Clostridium perfringens type A. Journal of Veterinary Diagnostic Investigation, 30(4), 495–503. https://doi.org/10.1177/1040638718766983
- Sindern, N., Suchodolski, J. S., Leutenegger, C. M., Mehdizadeh Gohari, I., Prescott, J. F., Proksch, A.-L., Mueller, R. S., Busch, K., & Unterer, S. (2019). Prevalence of Clostridium perfringens netE and netF toxin genes in the feces of dogs with acute hemorrhagic diarrhea syndrome. Journal of Veterinary Internal Medicine, 33(1), 100–105. https://doi.org/10.1111/jvim.15367
- Ziese, A.-L., Suchodolski, J. S., Hartmann, K., Busch, K., Anderson, A., Sarwar, F., Sindern, N., & Unterer, S. (2018). Effect of probiotic treatment on the clinical course, intestinal microbiome, and toxigenic Clostridium perfringens in dogs with acute hemorrhagic diarrhea. PLOS ONE, 13(9), Article e0204691. https://doi.org/10.1371/journal.pone.0204691
- Marks, S. L., Kather, E. J., Kass, P. H., & Melli, A. C. (2002). Genotypic and phenotypic characterization of Clostridium perfringens and Clostridium difficile in diarrheic and healthy dogs. Journal of Veterinary Internal Medicine, 16(5), 533–540. https://doi.org/10.1111/j.1939-1676.2002.tb02384.x
- Marks, S. L., Rankin, S. C., Byrne, B. A., & Weese, J. S. (2011). Enteropathogenic bacteria in dogs and cats: Diagnosis, epidemiology, treatment, and control. Journal of Veterinary Internal Medicine, 25(6), 1195–1208. https://doi.org/10.1111/j.1939-1676.2011.00821.x
- Park, J., Cheon, D., & Oh, Y. I. (2025). Prevalence and toxin gene profiles of Clostridium perfringens in diarrheic dogs and cats in Korea: A retrospective analysis. Journal of Veterinary Science, 26(4), Article e52. https://doi.org/10.4142/jvs.24361
- Wessely, V., Suchodolski, J. S., Cavasin, J. P., Holz, M., Busch-Hahn, K., & Unterer, S. (2025). Prevalence of Clostridium perfringens encoding the netF toxin gene in dogs with acute and chronic gastrointestinal diseases. Pets, 2, Article 9. https://doi.org/10.3390/pets2010009
- Gohari, I. M., Kropinski, A. M., Weese, S. J., Whitehead, A. E., Parreira, V. R., Boerlin, P., Prescott, J. F., & Slavić, D. (2020). NetF-producing Clostridium perfringens and its associated diseases in dogs and foals. Journal of Veterinary Diagnostic Investigation, 32(2), 230–238. https://doi.org/10.1177/1040638720906814
- Leipig-Rudolph, M., Busch, K., Prescott, J. F., Gohari, I. M., Leutenegger, C. M., Hermanns, W., Wolf, G., Hartmann, K., Verspohl, J., & Unterer, S. (2018). Intestinal lesions in dogs with acute hemorrhagic diarrhea syndrome associated with netF-positive Clostridium perfringens type A. Journal of Veterinary Diagnostic Investigation, 30(4), 495–503. https://doi.org/10.1177/1040638718766983
- Sindern, N., Suchodolski, J. S., Leutenegger, C. M., Mehdizadeh Gohari, I., Prescott, J. F., Proksch, A.-L., Mueller, R. S., Busch, K., & Unterer, S. (2019). Prevalence of Clostridium perfringens netE and netF toxin genes in the feces of dogs with acute hemorrhagic diarrhea syndrome. Journal of Veterinary Internal Medicine, 33(1), 100–105. https://doi.org/10.1111/jvim.15367
- Ziese, A.-L., Suchodolski, J. S., Hartmann, K., Busch, K., Anderson, A., Sarwar, F., Sindern, N., & Unterer, S. (2018). Effect of probiotic treatment on the clinical course, intestinal microbiome, and toxigenic Clostridium perfringens in dogs with acute hemorrhagic diarrhea. PLOS ONE, 13(9), Article e0204691. https://doi.org/10.1371/journal.pone.0204691
- Marks, S. L., Kather, E. J., Kass, P. H., & Melli, A. C. (2002). Genotypic and phenotypic characterization of Clostridium perfringens and Clostridium difficile in diarrheic and healthy dogs. Journal of Veterinary Internal Medicine, 16(5), 533–540. https://doi.org/10.1111/j.1939-1676.2002.tb02384.x
- Marks, S. L., Rankin, S. C., Byrne, B. A., & Weese, J. S. (2011). Enteropathogenic bacteria in dogs and cats: Diagnosis, epidemiology, treatment, and control. Journal of Veterinary Internal Medicine, 25(6), 1195–1208. https://doi.org/10.1111/j.1939-1676.2011.00821.x